Next Article in Journal
Cellular Effects of Cyclodextrins: Studies on HeLa Cells
Next Article in Special Issue
Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module
Previous Article in Journal
Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations
Previous Article in Special Issue
The Anthelmintic Quassinoids Ailanthone and Bruceine a Induce Infertility in the Model Organism Caenorhabditis elegans by an Apoptosis-like Mechanism Induced in Gonadal and Spermathecal Tissues
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 5
10.3390/molecules27051588
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Combination of GC-MS Molecular Networking and Larvicidal Effect against Aedes aegypti for the Discovery of Bioactive Substances in Commercial Essential Oils

by
Alan Cesar Pilon
1,†,
Marcelo Del Grande
1,†,
Maíra R. S. Silvério
1,
Ricardo R. Silva
1,
Lorena C. Albernaz
2,
Paulo Cézar Vieira
1,
João Luis Callegari Lopes
1,
Laila S. Espindola
2 and
Norberto Peporine Lopes
1,*
1
Núcleo de Pesquisa em Produtos Naturais e Sintéticos (NPPNS), Departamento de Ciências Biomoleculares, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo—USP, Ribeirão Preto 14040-903, Brazil
2
Laboratório de Farmacognosia, Campus Universitário Darcy Ribeiro, Universidade de Brasília, Brasília 70910-900, Brazil
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2022, 27(5), 1588; https://doi.org/10.3390/molecules27051588
Submission received: 25 January 2022 / Revised: 20 February 2022 / Accepted: 24 February 2022 / Published: 28 February 2022
(This article belongs to the Special Issue Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Therapeutics)
Browse Figures
Review Reports Versions Notes

Abstract

:
Dengue is a neglected disease, present mainly in tropical countries, with more than 5.2 million cases reported in 2019. Vector control remains the most effective protective measure against dengue and other arboviruses. Synthetic insecticides based on organophosphates, pyrethroids, carbamates, neonicotinoids and oxadiazines are unattractive due to their high degree of toxicity to humans, animals and the environment. Conversely, natural-product-based larvicides/insecticides, such as essential oils, present high efficiency, low environmental toxicity and can be easily scaled up for industrial processes. However, essential oils are highly complex and require modern analytical and computational approaches to streamline the identification of bioactive substances. This study combined the GC-MS spectral similarity network approach with larvicidal assays as a new strategy for the discovery of potential bioactive substances in complex biological samples, enabling the systematic and simultaneous annotation of substances in 20 essential oils through LC50 larvicidal assays. This strategy allowed rapid intuitive discovery of distribution patterns between families and metabolic classes in clusters, and the prediction of larvicidal properties of acyclic monoterpene derivatives, including citral, neral, citronellal and citronellol, and their acetate forms (LC50 < 50 µg/mL).

1. Introduction

Dengue is a viral infection transmitted mainly by the female Aedes aegypti mosquito. This disease mainly affects tropical regions, depending on the rain precipitation rate, temperature, humidity and urbanization process [1,2,3,4,5,6,7]. The number of cases has increased almost 8-fold over the last 2 decades (from 505,430 in 2000 to 2.4 million in 2010; 4.2 million in 2019), leading to the death of more than 4000 people in 2015. Regions of Latin America, East Asia and the Western Pacific account for over 70% of the cases. In Brazil, more than 1.5 million cases (more than 1000 deaths) were recorded in 2016 alone [1,7,8].
The WHO indicates that combatting the transmitting mosquito is the most efficient strategy to control and prevent dengue [9]. However, there are still no specific insecticides or repellents (natural or synthetic) to exclusively combat the Ae. Aegypti mosquito. Consequently, insecticides and repellents can cause disturbances and/or the mortality of important insects, such as bees and ants, resulting in the degradation of important ecosystem services, including the pollination of crops [9]. Thus, nontoxic and specific repellent agents or larvicides against Ae. aegypti are urgently required to both reduce the number of arboviral disease cases (dengue, Zika and chikungunya) and protect the ecological roles of insects.
In order to address the aforementioned concerns, the Brazilian National Dengue Control Program has promoted the replacement of these synthetic compounds with substances that are less harmful to the environment. Organophosphates (malathion, fenitrothion and temephos) initially replaced organochlorines, which were in turn replaced by pyrethroids (cypermethrin and deltamethrin). However, these compounds still present some toxicity and continue to endanger populations of pollinating insects, animals and the environment [8].
Since the last century, efforts have been made to source products of natural origin with activity against Ae. Aegypti, such as pyrethrum and neem oil; although, no commercial products have been approved/authorized by Brazilian regulatory bodies to date. The literature reports the potential of various natural insecticides, especially those of microbial and plant origin [10,11]. The arms race between insects, plants and microorganisms constitutes a large part of the known metabolic arsenal, the so-called secondary metabolites or “special” metabolites. Today, it is estimated that more than 100,000 plant-derived metabolites may have some activity against insects and microorganisms [12].
Among the advantages of natural pesticides/larvicides, we can highlight their environmental safety, biodegradation and multiple mechanisms of action through synergistic effects. However, while the biodegradation of botanical active ingredients may sound positive, it actually represents a double-edged sword. There is generally greater compatibility between the released biocontrol agents and other natural enemies and greater safety for bees and other pollinators [8,13]. However, the lack of persistence of these bio-insecticides in crops under real field conditions brings some disadvantages. Most botanical insecticides are highly susceptible to photodegradation (e.g., pyrethrins), abiotic oxidation (azadiractins) or volatilization loss (essential oil terpenoids) when applied outside a controlled environment (e.g., indoors), requiring their reapplication when used on monocultures. Despite this limitation, certain botanical insecticides have proven records dating back 2–3 decades, confirming their effectiveness in the field [14,15]. Between 2007 and 2016, the state of California used azadirachtin, chenopodium and natural pyrethrins as the main botanical assets for pest control. However, recent formulation developments present opportunities to dramatically improve the field performance of botanical insecticides in terms of their efficacy and persistence [16,17].
The search for larvicidal agents present in essential oils (EO), plants or natural extracts requires increasingly modern analytical and computational tools, since these natural products are composed of dozens and even hundreds of compounds [18,19,20,21]. Recently, innovative methods based on LC-MSn have been applied for untargeted metabolomic analysis to accelerate the structural annotation of compounds [12,22,23,24,25]. The increased sharing of experimental MS/MS data and the growing number of spectral databases, such as NIST, METLIN, MassBank, MASST, NuBBEDB, Sumner/Bruker and ReSpect, have promoted the development of several bioinformatics approaches that help in the interpretation of large MS/MS datasets [26,27,28,29,30,31,32,33].
One of these approaches is the concept of spectral similarity networking (so-called molecular networks—MN) which is based on the organization and visualization of MS/MS data via spectral similarity (homologous fragments) [24,34,35,36,37,38,39]. Structurally related compounds often share similar MS/MS spectra. The MN groups these compounds (nodes) according to the degree of spectral similarity as a network in a knowledge graph format, thus allowing visual exploration of identical/analogous molecules and accelerating the identification of subgroups or characteristics of a given group of molecules. Chemical annotation via molecular networking arises from the combination of direct spectral correspondence between MS/MS spectra and compound libraries (MS/MS data) and through the relationship of molecular network masses (differences) between closely related structures (degree of spectral similarity). A mass difference of 15 Da between nodes with a high degree of similarity may suggest a CH3 group for the same class of compound, while differences of 162, 146 or 132 Da may correspond to homologues glycosylated with hexose, deoxyhexose or pentose [36,39,40,41,42].
In this study, we propose a strategy combining the spectral similarity networking (molecular networking) approach with larvicidal activity tests against Ae. aegypti to analyze commercial essential oils with the aim of discovering potential bioactive metabolic classes. The GC-MS retention time and fragmentation, chemotaxonomy and larvicidal activity against Ae. aegypti (LC50 values) of essential oils were organized, grouped and evaluated by molecular networking. Figure 1 shows a graphical representation of the strategy.

2. Results

Essential oils from 20 plant species (from 9 families) with insecticidal properties were analyzed by an untargeted profiling method using GC-EI/MS (Supplementary Materials) and tested against Ae. aegypti larvae (third instar, L3), evaluating their mortality rate at 24 h and 48 h, Table 1. According to Dermaque et al. [43], an initial screening strategy to preselect an extract active against Ae. aegypti larvae involves testing at a single concentration, standardized at 250 ppm.
Species of the genera Lavandula, Cymbopogon, Rosmarinus, Citrus, Perlagonium and Amyris demonstrated larvicidal activity, while the other essential oils presented little or no activity. Among them, it is noted that the essential oils of the genus Eucalyptus, as well as the species of Cymbopogon and Litsea, had highly active LC50 values of: Eucalyptus citriodora (23.3 µg/mL), Eucalyptus staigeriana (43.1 µg/mL), Cymbopogon nardus (31.3 µg/mL), Cymbopogon flexuosus (41.7 µg/mL) and Litsea cubeba (32.7 µg/mL).
In order to annotate and streamline the process of discovering bioactive classes in essential oils, we applied the molecular network approach with retention time and fragmentation data from the GC-MS/MS experiments and metadata, such as taxonomy and LC50 values calculated in the Ae. aegypti larvicidal tests.

Molecular Networking

The molecular network of 20 essential oils resulted in 82 nodes (with qualitative, quantitative and metadata for each compound), connected by 258 edges and grouped into a large cluster with 76 nodes and 6 lone pairs, as shown in Figure 2. One of the advantages of MN is the ability to create filters for nodes and edges in order to recognize patterns in the dataset. In this sense, different colors were attributed to nodes considering the retention time of the compounds present in the GC-MS profiles (red—longer RT; yellow—shorter RT) and to the relative abundance of ions represented by the node sizes (Figure 2).
The distribution of colors in the cluster regions indicated that different classes of metabolites must be grouped differently. In addition, most of the compounds (nodes) were eluted between 7 and 20 min, which may denote certain metabolic classes and, consequently, assist in the annotation process.
Another aspect is to evaluate the correlation of these compounds between families and their chemotaxonomic characteristics. It is also possible to make an indirect association between the chemotypes and the larvicidal potential of the cluster regions.
Figure 3 shows the MN using the compound distribution filter (relative abundance of ions) among the families using a color gradient in the nodes. Yellow represents little or no abundance, while blue represents a high abundance of ions. The Burseraceae and Cupressaceae families presented a strong correlation with most of their compounds (nodes) located in the region with the lowest retention times. Geraniaceae and Lamiaceae displayed a wide distribution of their compounds in the MN, while metabolites in Lauraceae, Myrtaceae, Poaceae and Rutaceae were observed between 7 and 20 min. Pinaceae concentrated its compounds in longer retention times.
Larvicidal activity against Ae. aegypti was used as a filter for the third step of evaluating the molecular network of commercial essential oils. The LC50 values (Table 1) from essential oils were used in two different ways to calculate the individual larvicidal activity for each node (substance). First, we calculated the average of the LC50 values for each node (one substance may be present in different EO), Figure 4A. Alternatively, we calculated the relative average considering ion abundance (present differently in each EO) for each node, Figure 4B. In both molecular networks (Figure 4A,B), we colored the maximum and minimum calculated LC50 values in four equidistant categories. The pink color represents the most active nodes, followed by blue, green and yellow. Although the ranges were different between the different averages, the color pattern was similar.
As a result, it was possible to observe three regions of molecular network with different larvicidal potentials. It is important to emphasize that these regions are projections of bioactivity, but may be used as a guide for regions/compounds to be explored and studied. In this case, for both averages (molecular networks) the lower right side of the cluster, colored in pink and blue, suggests a region with higher larvicidal potential. In Figure 4B, there is also a pink diagonal projecting this potential.
The fourth filter of this molecular networking was to annotate the nodes. We used the GNPS library combined with our in-house NIST database and gas-phase fragmentation data. The annotated compounds were then classified hierarchically according to the NP-Classifier ontology [44], as shown in Figure 5.
Figure 5 represents the filtered molecular network for compound annotation. The ellipse represents the level of the superclass (terpenes), while the colors represent the distribution of classes into monoterpenes (orange) and sesquiterpenes (purple). In the lower part of Figure 5, it is possible to observe the group of expanded monoterpenes and sesquiterpenes. Eight subclasses were found for monoterpenes: acyclic (orange), camphane (green), fatty alcohols (light blue), menthane (blue), monocyclic (purple), pinane (pink) and thujan (red), while six subclasses were classified as sesquiterpenes: cadinan (yellow), caryophyllane (green), elemane (light blue), germacrane (blue), himachalane (dark blue) and longifolene (pink) alcohols.
The potential bioactive nodes were annotated and classified as acyclic (orange), camphane (green) and menthane/monocyclic monoterpenes (dark blue). Specifically, the compounds with the lower LC50 values were annotated as citral (polyunsaturated and aldehyde as a functional group (FG)), neral (FG-aldehyde), citronellal (monoterpene-unsaturated and FG-aldehyde), citronellol (unsaturated and FG-alcohol), citronellol acetate (unsaturated and FG-acetate), isopulegol (unsaturated, monocyclic and FG-alcohol), linalool (poly-unsaturated and FG-alcohol), camphor (menthane and FG-ketone), and endo-borneol (menthane and FG-ketone).
Table 2 shows the list of annotated compounds, retention time (min), precursor ion values (m/z), samples and relative LC50 values.
To verify the predictive potential of the strategy to discover larvicides in essential oils, we tested some of the monoterpenes indicated by MN against Ae. aegypti larvae and calculated their LC50 values after 48 h exposure. Among the compounds tested were: α-fenchene (>100 µg/mL); eucalyptol (>100 µg/mL); menthol (>100 µg/mL); citronellol (65.3 µg/mL); citronellal (57.8 µg/mL); cymol (41.7 µg/mL); citral (40.1 µg/mL); α-phellandrene (40.1 µg/mL) and D-limonene (27.1 µg/mL).
Similarly, we projected the LC50 values of the tested compounds onto the molecular network to confirm the pharmacological patterns pointed out by MN, Figure 6. As a result, the diagonal indicated by MN including acyclic, monocyclic monoterpenes and menthane-type monoterpenes were active against Ae. aegypti larvae. In addition, some menthane-type monoterpene derivatives, such as D-limonene, were highly active.

3. Discussion

Essential oils and their structural analogues have historically made an important contribution as repellents or insecticides against Ae. aegypti in different communities [8,14,45,46]. However, larvicide/insecticide products based on natural products (NP) are scarce in the industry, revealing some difficulties associated with applying traditional approaches in NP [43,47,48].
Typically, a traditional approach uses organic solvents to produce crude extracts (polar or non-polar) that are screened for pharmacological activities and then fractionated into dozens of portions for further iterative bioguided analyses. In each cycle, the active fractions are reassembled after verification with spectral experiments, which can range from simple UV light to more expensive NMR analyses. Thus, the cost of pinpointing the NP-based product by traditional methods is high when considering that hundreds of extracts need to be analyzed to find a hit molecule [47,49].
This challenge has been partially addressed through the development of dereplication methods, which aim to prioritize the discovery of bioactive substances, still in the crude extract, avoiding the re-isolation of interferents or known compounds. Dereplication uses previously established data (spectroscopic data, pharmacological and physicochemical properties) present in databases, scientific literature and computational tools to compare samples and reference material and, therefore, annotate and to attribute some properties to substances still in extracts or fractions. Despite offering advantages over traditional methods, this strategy faces some obstacles, as follows: (1) the databases and literature are not comprehensive and standardized, rendering it difficult to discover non-ubiquitous compounds; (2) the comparison process is still univariate between the sample(s) and the reference material, making the whole process time-consuming; (3) the global relationships between samples and metabolites are little explored [18,25,50,51].
On the other hand, chemometrics and bioinformatics have faced these obstacles introducing a holistic view of how to manage data and especially how to extract relevant information from vast datasets. Some of the strategies employed in genomics and proteomics are gradually being introduced into NP science. One such strategy is the use of spectral similarity information (or any other molecular data) that can provide clues as to how the constituents of a sample are organized (classes, substituents and properties) [38,40,52,53,54].
This organization concept is already used in the GNPS platform generating spectral networks of MS/MS data. Therefore, not only can single samples be screened for similarity, but hundreds or even thousands of samples can be organized into a single network, the so-called molecular network. Thus, using a spectral similarity score (cosine score) we can organize families, classes, substituents from one or several samples at once and still discover distribution patterns of unknown metabolites [25,55,56,57,58,59].
However, several parameters need to be adjusted to extract relevant information from the MS/MS data. In LC-MS, MS/MS experiments are performed in data dependent analysis (DDA), which means that each ion is initially isolated from the others, fragmented and then analyzed (collected). In contrast, most GC-MS systems do not possess an ion isolation chamber and the separation of substances depends on chromatographic resolution, which is often insufficient to separate all of the metabolites. This results in the fragmentation of more than one substance at the same time, making it difficult to apply spectral comparison (similarity) tools between samples and the reference [53,60].
In this sense, our strategy largely overcomes these limitations, since the MS/MS spec-tral data from GC-MS are initially deconvoluted and aligned by the Mzmine 2 tool and then compared and organized by spectral similarity networking (molecular network GNPS). As shown in Figure 2, Figure 3, Figure 4, Figure 5 and Figure 6, it is possible to clearly visualize how substances are distributed throughout the chromatographic analysis, showing potential metabolic classes with different fragmentation profiles. It was possible to group information at the family level and discover patterns among them. We noticed that some families share similar MS/MS profiles, some of which have similar pharmacological properties. This allows us to extract chemotaxonomic information and prioritize bioactive families [61].
The incorporation of metadata into the molecular network opens up new opportunities to discover unknown patterns in samples. The relative mean of LC50 values from larvicidal experiments in Ae. aegypti, in several samples, allowed us to estimate the pharmacological effect of individual compounds that were repeatedly present in the samples and also indicate the bioactive ones. This is an innovative strategy in terms of discovering bioactive compounds in crude extracts, particularly in GC-MS experiments.
We annotated compounds quickly and easily using our in-house library combined with the molecular network. Using the unknown to known annotation principle, the compounds determined by the library were used in the network to evaluate the neighbors (similar) and their spectra, facilitating and speeding up the annotation. During this process we also noticed that pharmacological patterns were associated with some metabolic classes such as acyclic, monocyclic and methane monoterpenes. Furthermore, they rationally shared some characteristics such as the presence of oxygen in the form of an alcohol or carbonyl group (acetate, aldehyde or ketone), an unsaturation index between 1 and 3, and masses between 152 and 156 Da. This suggests that this strategy can be employed to indicate potentially promising chemical classes.
Finally, we tested the larvicidal activity of some of the isolated monoterpenes, revealing the bioactive potential of some of them. We therefore confirmed the potential of the strategy to not only predict the pharmacological activity of compounds in crude extracts and fractions, but also facilitate pattern recognition in samples and metabolites.

4. Materials and Methods

The essential oils were purchased from BioEssência®, Jaú, Brazil, and analyzed by dissolving in ethyl acetate at a concentration of 5 µg/mL. Table 1 details the percentages of the major compounds in each essential oil.

4.1. Larvicidal Activity against Ae. aegypti

Larvicidal tests were performed with the Ae. aegypti Rockefeller strain. Third instar larvae (L3) were obtained from infection-free colonies maintained in the insectary of the Laboratory of Pharmacognosy of the University of Brasília. Colony maintenance is in accordance with World Health Organization guidelines [62] Monthly monitoring of this strain, which is susceptible to insecticides, using dose–response curves performed in 12-well plates with 10 L3 larvae, with temephos as the positive control (concentrations ranging from 0.05 to 0.003125 µg/mL).
We optimized the WHO larvicidal trial to perform rapid screening and subsequent scale-up without harm. Assays were performed as described by Silva et al., 2020 [63], using 12-well plates, with 3 mL of tap water, 10 L3 larvae and 50 µL of sample diluted in DMSO. This test is rapid, uses a small sample and allows the screening of many essential oil samples for major compounds.
The samples were tested in quadruplicate using a negative control of 0.025% dimethyl sulfoxide in tap water at pH 7.75, conductivity at 34.5 µS/cm and temephos as the positive control. This organophosphate is used as a positive control due to its efficiency against Ae. aegypti Rockefeller strain (100% mortality at 0.35 µg/mL after 24 and 48 h with LC50 of 0.019 µg/mL), being used in private companies in Brazil as a pest control agent.
For initial screening, only the mortalities of essential oils at the final concentration of 250 µg/mL were determined, after 24 h and 48 h. The 50% lethal concentration values (LC50 µg/mL) were estimated using the test concentrations 250, 125, 62.5 and 31.25 µg/mL for the essential oils and 100, 50, 25, 12.5 and 6.25 µg/mL for pure compounds (GraphPad Prism 7.0 software, GraphPad, La Jolla, CA, USA). Larvae mortality was determined after a 24 h exposure treatment. For each bioassay, the temperature was maintained at 28 ± 2 °C and 70 ± 10% RH, with a 12 h photoperiod.

4.2. GC-MS Analysis

For the essential oil analysis, we used the analytical methodology described by Adams (2007) with adaptations. Analysis involved gas chromatography coupled with mass spectrometer detection (GCMS-QP2010) according to the following parameters: injector temperature, 250 °C; column temperature, 60 °C; heating ramp from 60 to 210 °C, at 3 °C/min, with a total time of 50 min; chromatographic column, DB-5, 30 m × 0.25 mm in diameter, 0.25 µm in thickness; helium was used as the carrier gas, under 79.7 kPa at 1.30 mL/min, with a linear velocity of 41.6 cm/s and 1 µL injection volume and a 1:60 split.
The mass detector parameters were as follows: ion source temperature, 250 °C; interface temperature, 260 °C; solvent cutoff at 3.0 min; Scan mode, from 35 to 400 m/z; detector voltage, 0 kV.

4.3. Molecular Networking

GC-EI/MS data were initially processed using the GCsolution (Shimadzu—Tokyo, Japan). Mass spectrometry molecular networks were created using the GNPS platform (http://gnps.ucsd.edu, accessed on 30 November 2021) [35,64]. As the mass data from the EI experiments did not present pre-selection of precursor ions (called acquisition format of DIA), a spectral deconvolution was necessary. To achieve this, GC-MS data were analyzed and processed using the MzMine 2 package according to the parameters shown in Table 3.
The files were submitted for processing by the spectral networks algorithm (GNPS) in three files: mgf file of the EI spectra deconvoluted by Mzmine 2, a quantification table of the peaks generated by Mzmine 2 and a metadata table, with information on the samples, such as LC50, taxonomy, coding, etc. In GNPS, the data were adjusted as follows: fragment ion mass tolerance of 0.5 Da; min matched peaks of 5; score threshold of 0.5. The advanced search options were: library class bronze; top history per spectrum of 1 and NIST and GNPS spectral libraries. In advanced network options: min pair cos 0.6 and network topK 10. For more details of the network on the GNPS, access: https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=e980401aaf22484f83adead45f6012dc, accessed on 30 November 2021.
Network visualization was performed in Cytoscape v.3.4.3. Node colors and sizes were mapped based on the metadata files, and the edge thickness attribute set to reflect cosine similarity scores, with thicker lines indicating greater similarity [65,66].

Supplementary Materials

The following supporting information can be downloaded, Figures S1–S5 represent GC-EI/MS chromatograms of commercial essential oils tested for larvicidal activity against Ae. aegypti larvae. Essential oils: Juniperus communis (Cupressaceae); Origanum majorana (Lamiaceae); Cymbopogon martini (Poaceae); Boswellia carteri (Burseraceae); Mentha piperita (Lamiaceae); Citrus aurantium var. amara (Rutaceae); Eucalyptus citriodora (Myrtaceae); Eucalyptus globulus (Myrtaceae); Lavandula angustifolia (Lamiaceae); Lavandula hybrida (Lamiaceae); Cymbopogon flexuosus (Poaceae); Cymbopogon nardus (Poaceae); Cedrus atlantica (Pinaceae); Rosmarinus officinalis (Lamiaceae); Citrus aurantium subsp. Bergamia (Rutaceae); Perlagonium graveolens (Geraniaceae); Litsea cubeba (Lauraceae); Salvia sclareia (Lamiaceae); Amyris balsamifera (Rutaceae) and Eucalyptus staigeriana (Myrtaceae).

Author Contributions

Conceptualization, A.C.P., M.D.G., M.R.S.S. and N.P.L.; methodology, A.C.P., R.R.S. and M.R.S.S.; formal analysis, M.R.S.S. and L.C.A.; investigation, A.C.P. and M.D.G.; resources, L.S.E.; writing—original draft preparation, A.C.P.; writing—review and editing, A.C.P., M.R.S.S., P.C.V., J.L.C.L., N.P.L. and L.S.E. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Brazilian Ministry of Health under Project ArboControl process no. TED 74/2016 and TED 42/2017. Additionally, to the following grants: process no.: 807/2020 (A.C.P), 142/2018 (M.D.G.) and 270/2017 (M.R.R.S) and FAPESP Thematic Project 2020/02207-5. The authors also acknowledge the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES; finance code 001) and The Research Network Natural Products against Neglected Diseases (ResNet NPND).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bhatt, S.; Gething, P.W.; Brady, O.J.; Messina, J.P.; Farlow, A.W.; Moyes, C.L.; Drake, J.M.; Brownstein, J.S.; Hoen, A.G.; Sankoh, O.; et al. The global distribution and burden of dengue. Nature 2013, 496, 504–507. [Google Scholar] [CrossRef] [PubMed]
  2. Whitmire, R.E.; Burke, D.S.; Nisalak, A.; Harrison, B.A.; Watts, D.M. Effect of Temperature on the Vector Efficiency of Aedes aegypti for Dengue 2 Virus. Am. J. Trop. Med. Hyg. 1987, 36, 143–152. [Google Scholar] [CrossRef]
  3. Duong, V.; Lambrechts, L.; Paul, R.E.; Ly, S.; Lay, R.S.; Long, K.C.; Huy, R.; Tarantola, A.; Scott, T.W.; Sakuntabhai, A.; et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc. Natl. Acad. Sci. USA 2015, 112, 14688–14693. [Google Scholar] [CrossRef] [Green Version]
  4. Dai, D.N.; Chung, N.T.; Huong, L.T.; Hung, N.H.; Chau, D.T.M.; Yen, N.T.; Setzer, W.N. Chemical Compositions, Mosquito Larvicidal and Antimicrobial Activities of Essential Oils from Five Species of Cinnamomum Growing Wild in North Central Vietnam. Molecules 2020, 25, 1303. [Google Scholar] [CrossRef] [Green Version]
  5. Nguyen, N.M.; Thi Hue Kien, D.; Tuan, T.V.; Quyen, N.T.H.; Tran, C.N.B.; Vo Thi, L.; Thi, D.L.; Nguyen, H.L.; Farrar, J.J.; Holmes, E.C.; et al. Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes. Proc. Natl. Acad. Sci. USA 2013, 110, 9072–9077. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Basurko, C.; Matheus, S.; Hildéral, H.; Everhard, S.; Restrepo, M.; Cuadro-Alvarez, E.; Lambert, V.; Boukhari, R.; Duvernois, J.-P.; Favre, A.; et al. Estimating the Risk of Vertical Transmission of Dengue: A Prospective Study. Am. J. Trop. Med. Hyg. 2018, 98, 1826–1832. [Google Scholar] [CrossRef] [Green Version]
  7. Waggoner, J.J.; Gresh, L.; Vargas, M.J.; Ballesteros, G.; Tellez, Y.; Soda, K.J.; Sahoo, M.K.; Nuñez, A.; Balmaseda, A.; Harris, E.; et al. Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus. Clin. Infect. Dis. 2016, 63, 1584–1590. [Google Scholar] [CrossRef]
  8. Silvério, M.R.S.; Espindola, L.S.; Lopes, N.P.; Vieira, P.C. Plant Natural Products for the Control of Aedes aegypti: The Main Vector of Important Arboviruses. Molecules 2020, 25, 3484. [Google Scholar] [CrossRef] [PubMed]
  9. WHO. Available online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (accessed on 15 January 2022).
  10. Zebitz, C.P.W. Effects of three different neem seed kernel extracts and azadirachtin on larvae of different mosquito species. J. Appl. Entomol. 1986, 102, 455–463. [Google Scholar] [CrossRef]
  11. Dua, V.K.; Pandey, A.C.; Raghavendra, K.; Gupta, A.; Sharma, T.; Dash, A.P. Larvicidal activity of neem oil (Azadirachta indica) formulation against mosquitoes. Malar. J. 2009, 8, 124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Pilon, A.C.; Valli, M.; Dametto, A.C.; Pinto, M.E.F.; Freire, R.T.; Castro-Gamboa, I.; Andricopulo, A.D.; Bolzani, V.S. NuBBEDB: An updated database to uncover chemical and biological information from Brazilian biodiversity. Sci. Rep. 2017, 7, 7215. [Google Scholar] [CrossRef]
  13. Park, H.-M.; Kim, J.; Chang, K.-S.; Kim, B.-S.; Yang, Y.-J.; Kim, G.-H.; Shin, S.-C.; Park, I.-K. Larvicidal Activity of Myrtaceae Essential Oils and Their Components Against Aedes aegypti, Acute Toxicity on Daphnia magna, and Aqueous Residue. J. Med. Entomol. 2011, 48, 405–410. [Google Scholar] [CrossRef] [PubMed]
  14. Isman, M.B. Botanical Insecticides in the Twenty-First Century—Fulfilling Their Promise? Annu. Rev. Entomol. 2020, 65, 233–249. [Google Scholar] [CrossRef] [Green Version]
  15. Isman, M.B. Bridging the gap: Moving botanical insecticides from the laboratory to the farm. Ind. Crops Prod. 2017, 110, 10–14. [Google Scholar] [CrossRef]
  16. De Oliveira, J.L.; Campos, E.V.R.; Bakshi, M.; Abhilash, P.C.; Fraceto, L.F. Application of nanotechnology for the encapsulation of botanical insecticides for sustainable agriculture: Prospects and promises. Biotechnol. Adv. 2014, 32, 1550–1561. [Google Scholar] [CrossRef] [PubMed]
  17. Sahayaraj, K. Nanotechnology and Plant Biopesticides: An Overview. In Advances in Plant Biopesticides; Springer: New Delhi, India, 2014; pp. 279–293. [Google Scholar]
  18. Wolfender, J.L.; Marti, G.; Thomas, A.; Bertrand, S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A 2015, 1382, 136–164. [Google Scholar] [CrossRef] [PubMed]
  19. Neto, F.C.; Pilon, A.C.; Selegato, D.M.; Freire, R.T.; Gu, H.; Raftery, D.; Lopes, N.P.; Castro-Gamboa, I. Dereplication of natural products using GC-TOF mass spectrometry: Improved metabolite identification by spectral deconvolution ratio analysis. Front. Mol. Biosci. 2016, 3, 59. [Google Scholar] [CrossRef] [Green Version]
  20. Čajka, T.; Hajšlová, J. Gas chromatography–high-resolution time-of-flight mass spectrometry in pesticide residue analysis: Advantages and limitations. J. Chromatogr. A 2004, 1058, 251–261. [Google Scholar] [CrossRef] [PubMed]
  21. Segers, K.; Declerck, S.; Mangelings, D.; Heyden, Y.V.; Van Eeckhaut, A. Analytical techniques for metabolomic studies: A review. Bioanalysis 2019, 11, 2297–2318. [Google Scholar] [CrossRef]
  22. Bandeira, N.; Tsur, D.; Frank, A.; Pevzner, P.A. Protein identification by spectral networks analysis. Proc. Natl. Acad. Sci. USA 2007, 104, 6140–6145. [Google Scholar] [CrossRef] [Green Version]
  23. Fox Ramos, A.E.; Alcover, C.; Evanno, L.; Maciuk, A.; Litaudon, M.; Duplais, C.; Bernadat, G.; Gallard, J.F.; Jullian, J.C.; Mouray, E.; et al. Revisiting Previously Investigated Plants: A Molecular Networking-Based Study of Geissospermum laeve. J. Nat. Prod. 2017, 80, 1007–1014. [Google Scholar] [CrossRef]
  24. Aksenov, A.A.; Da Silva, R.; Knight, R.; Lopes, N.P.; Dorrestein, P.C. Global chemical analysis of biology by mass spectrometry. Nat. Rev. Chem. 2017, 1, 54. [Google Scholar] [CrossRef]
  25. Yang, J.Y.; Sanchez, L.M.; Rath, C.M.; Liu, X.; Boudreau, P.D.; Bruns, N.; Glukhov, E.; Wodtke, A.; De Felicio, R.; Fenner, A.; et al. Molecular networking as a dereplication strategy. J. Nat. Prod. 2013, 76, 1686–1699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Pluskal, T.; Castillo, S.; Villar-Briones, A.; Orešič, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform. 2010, 11, 395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Olivon, F.; Grelier, G.; Roussi, F.; Litaudon, M.; Touboul, D. MZmine 2 Data-Preprocessing to Enhance Molecular Networking Reliability. Anal. Chem. 2017, 89, 7836–7840. [Google Scholar] [CrossRef]
  28. Röst, H.L.; Sachsenberg, T.; Aiche, S.; Bielow, C.; Weisser, H.; Aicheler, F.; Andreotti, S.; Ehrlich, H.-C.; Gutenbrunner, P.; Kenar, E.; et al. OpenMS: A flexible open-source software platform for mass spectrometry data analysis. Nat. Methods 2016, 13, 741–748. [Google Scholar] [CrossRef]
  29. Tsugawa, H.; Cajka, T.; Kind, T.; Ma, Y.; Higgins, B.; Ikeda, K.; Kanazawa, M.; Vandergheynst, J.; Fiehn, O.; Arita, M. MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 2015, 12, 523–526. [Google Scholar] [CrossRef] [PubMed]
  30. Shen, V.K.; Siderius, D.W.; Krekelberg, W.P.; Hatch, H.W. NIST Standard Reference Simulation Website. NIST Stand. Ref. Database Number 173. Available online: https://doi.org/10.18434/T4M88Q (accessed on 15 November 2021).
  31. Smith, C.A.; Maille, G.O.; Want, E.J.; Qin, C.; Trauger, S.A.; Brandon, T.R.; Custodio, D.E.; Abagyan, R.; Siuzdak, G. Metlin: A metabolite mass spectral database. Ther. Drug Monit. 2005, 27, 747–751. [Google Scholar] [CrossRef] [PubMed]
  32. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K.; et al. MassBank: A public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 2010, 45, 703–714. [Google Scholar] [CrossRef]
  33. Hodgson, J. Mass spectrometry searches using MASST. Nat. Biotechnol. 2020, 38, 19–22. [Google Scholar] [CrossRef]
  34. Nothias, L.F.; Petras, D.; Schmid, R.; Dührkop, K.; Rainer, J.; Sarvepalli, A.; Protsyuk, I.; Ernst, M.; Tsugawa, H.; Fleischauer, M.; et al. Feature-based molecular networking in the GNPS analysis environment. Nat. Methods 2020, 17, 905–908. [Google Scholar] [CrossRef] [PubMed]
  35. Watrous, J.; Roach, P.; Alexandrov, T.; Heath, B.S.; Yang, J.Y.; Kersten, R.D.; Van Der Voort, M.; Pogliano, K.; Gross, H.; Raaijmakers, J.M.; et al. Mass spectral molecular networking of living microbial colonies. Proc. Natl. Acad. Sci. USA 2012, 109, 1743–1752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Pilon, A.C.; Gu, H.; Raftery, D.; da Silva Bolzani, V.; Lopes, N.P.; Castro-Gamboa, I.; Carnevale Neto, F. Mass Spectral Similarity Networking and Gas-Phase Fragmentation Reactions in the Structural Analysis of Flavonoid Glycoconjugates. Anal. Chem. 2019, 91, 10413–10423. [Google Scholar] [CrossRef] [PubMed]
  37. Chacon, D.S.; Torres, T.M.; da Silva, I.B.; de Araújo, T.F.; Roque, A.D.A.; Pinheiro, F.A.S.D.; Selegato, D.; Pilon, A.; Reginaldo, F.P.S.; da Costa, C.T.; et al. Erythrina velutina Willd. alkaloids: Piecing biosynthesis together from transcriptome analysis and metabolite profiling of seeds and leaves. J. Adv. Res. 2021, 34, 123–136. [Google Scholar] [CrossRef]
  38. Pilon, A.C.; Vieira, N.C.; Amaral, J.G.; Monteiro, A.F.; Da Silva, R.R.; Spíndola, L.S.; Castro-Gamboa, I.; Lopes, N.P. Molecular networks: An analysis on annotations and discovery of new assets. Quim. Nova 2021, 44, 1168–1179. [Google Scholar] [CrossRef]
  39. Conde-Martínez, N.; Bauermeister, A.; Pilon, A.; Lopes, N.; Tello, E. Integrating Molecular Network and Culture Media Variation to Explore the Production of Bioactive Metabolites by Vibrio diabolicus A1SM3. Mar. Drugs 2019, 17, 196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Fox Ramos, A.E.; Evanno, L.; Poupon, E.; Champy, P.; Beniddir, M.A. Natural products targeting strategies involving molecular networking: Different manners, one goal. Nat. Prod. Rep. 2019, 36, 960–980. [Google Scholar] [CrossRef] [PubMed]
  41. Selegato, D.M.; Freire, R.T.; Pilon, A.C.; Biasetto, C.R.; de Oliveira, H.C.; de Abreu, L.M.; Araujo, A.R.; da Silva Bolzani, V.; Castro-Gamboa, I. Improvement of bioactive metabolite production in microbial cultures—A systems approach by OSMAC and deconvolution-based 1HNMR quantification. Magn. Reson. Chem. 2019, 57, 458–471. [Google Scholar] [CrossRef] [PubMed]
  42. Neto, F.C.; Raftery, D. Expanding Urinary Metabolite Annotation through Integrated Mass Spectral Similarity Networking. Anal. Chem. 2021, 93, 12001–12010. [Google Scholar] [CrossRef]
  43. Demarque, D.P.; Espindola, L.S. Challenges, Advances and Opportunities in Exploring Natural Products to Control Arboviral Disease Vectors. Front. Chem. 2021, 9, 779049. [Google Scholar] [CrossRef] [PubMed]
  44. Kim, H.W.; Wang, M.; Leber, C.A.; Nothias, L.-F.; Reher, R.; Kang, K.B.; van der Hooft, J.J.J.; Dorrestein, P.C.; Gerwick, W.H.; Cottrell, G.W. NPClassifier: A Deep Neural Network-Based Structural Classification Tool for Natural Products. J. Nat. Prod. 2021, 84, 2795–2807. [Google Scholar] [CrossRef] [PubMed]
  45. Lubes, G.; Goodarzi, M. Analysis of Volatile Compounds by Advanced Analytical Techniques and Multivariate Chemometrics. Chem. Rev. 2017, 117, 6399–6422. [Google Scholar] [CrossRef] [PubMed]
  46. Dyer, L.A.; Philbin, C.S.; Ochsenrider, K.M.; Richards, L.A.; Massad, T.J.; Smilanich, A.M.; Forister, M.L.; Parchman, T.L.; Galland, L.M.; Hurtado, P.J.; et al. Modern approaches to study plant–insect interactions in chemical ecology. Nat. Rev. Chem. 2018, 2, 50–64. [Google Scholar] [CrossRef]
  47. Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M.; Orhan, I.E.; Banach, M.; Rollinger, J.M.; Barreca, D.; Weckwerth, W.; Bauer, R.; Bayer, E.A.; et al. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021, 20, 200–216. [Google Scholar] [CrossRef] [PubMed]
  48. Harvey, A.L.; Edrada-Ebel, R.; Quinn, R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 2015, 14, 111–129. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Schirle, M.; Jenkins, J.L. Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov. Today 2016, 21, 82–89. [Google Scholar] [CrossRef]
  50. Gaudêncio, S.P.; Pereira, F. Dereplication: Racing to speed up the natural products discovery process. Nat. Prod. Rep. 2015, 32, 779–810. [Google Scholar] [CrossRef]
  51. Neto, F.C.; Siquitelli, C.D.; Pilon, A.C.; Silva, D.H.S.; Bolzani, V.D.S.; Castro-Gamboa, I. Dereplication of phenolic derivatives of qualea grandiflora and qualea cordata (vochysiaceae) using liquid chromatography coupled with ESI-QToF-MS/MS. J. Braz. Chem. Soc. 2013, 24, 758–764. [Google Scholar] [CrossRef]
  52. Aron, A.T.; Gentry, E.C.; McPhail, K.L.; Nothias, L.F.; Nothias-Esposito, M.; Bouslimani, A.; Petras, D.; Gauglitz, J.M.; Sikora, N.; Vargas, F.; et al. Reproducible molecular networking of untargeted mass spectrometry data using GNPS. Nat. Protoc. 2020, 15, 1954–1991. [Google Scholar] [CrossRef] [PubMed]
  53. Yue, Y.; Zhang, Q.; Wang, J. Integrated Gas Chromatograph-Mass Spectrometry (GC/MS) and MS/MS-Based Molecular Networking Reveals the Analgesic and Anti-Inflammatory Phenotypes of the Sea Slater Ligia exotica. Mar. Drugs 2019, 17, 395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Olivon, F.; Apel, C.; Retailleau, P.; Allard, P.M.; Wolfender, J.L.; Touboul, D.; Roussi, F.; Litaudon, M.; Desrat, S. Searching for original natural products by molecular networking: Detection, isolation and total synthesis of chloroaustralasines. Org. Chem. Front. 2018, 5, 2171–2178. [Google Scholar] [CrossRef]
  55. Kang, K.B.; Ernst, M.; van der Hooft, J.J.J.; da Silva, R.R.; Park, J.; Medema, M.H.; Sung, S.H.; Dorrestein, P.C. Comprehensive mass spectrometry-guided phenotyping of plant specialized metabolites reveals metabolic diversity in the cosmopolitan plant family Rhamnaceae. Plant J. 2019, 98, 1134–1144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Leão, T.; Wang, M.; Moss, N.; da Silva, R.; Sanders, J.; Nurk, S.; Gurevich, A.; Humphrey, G.; Reher, R.; Zhu, Q.; et al. A Multi-Omics Characterization of the Natural Product Potential of Tropical Filamentous Marine Cyanobacteria. Mar. Drugs 2021, 19, 20. [Google Scholar] [CrossRef]
  57. Nothias, L.F.; Nothias-Esposito, M.; Da Silva, R.; Wang, M.; Protsyuk, I.; Zhang, Z.; Sarvepalli, A.; Leyssen, P.; Touboul, D.; Costa, J.; et al. Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation. J. Nat. Prod. 2018, 81, 758–767. [Google Scholar] [CrossRef] [Green Version]
  58. Da Silva, R.R.; Wang, M.; Nothias, L.F.; van der Hooft, J.J.J.; Caraballo-Rodríguez, A.M.; Fox, E.; Balunas, M.J.; Klassen, J.L.; Lopes, N.P.; Dorrestein, P.C. Propagating annotations of molecular networks using in silico fragmentation. PLoS Comput. Biol. 2018, 14, e1006089. [Google Scholar] [CrossRef]
  59. Naman, C.B.; Rattan, R.; Nikoulina, S.E.; Lee, J.; Miller, B.W.; Moss, N.A.; Armstrong, L.; Boudreau, P.D.; Debonsi, H.M.; Valeriote, F.A.; et al. Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium. J. Nat. Prod. 2017, 80, 625–633. [Google Scholar] [CrossRef] [PubMed]
  60. Aksenov, A.A.; Laponogov, I.; Zhang, Z.; Doran, S.L.F.; Belluomo, I.; Veselkov, D.; Bittremieux, W.; Nothias, L.F.; Nothias-Esposito, M.; Maloney, K.; et al. Autodeconvolution and molecular networking og gas chromatography-mass spectrometry data. Nat. Biotechnol. 2021, 39, 169–173. [Google Scholar] [CrossRef]
  61. Jing, L.; Lei, Z.; Zhang, G.; Pilon, A.C.; Huhman, D.V.; Xie, R.; Xi, W.; Zhou, Z.; Sumner, L.W. Metabolite profiles of essential oils in citrus peels and their taxonomic implications. Metabolomics 2015, 11, 952–963. [Google Scholar] [CrossRef]
  62. WHO. Guidelines for Laboratory and Field Testing of Mosquitos Larvicides; WHO: Geneva, Switzerland, 2005. Available online: https://apps.who.int/iris/handle/10665/69101 (accessed on 15 November 2021).
  63. Silva, R.L.; Demarque, D.P.; Dusi, R.G.; Sousa, J.P.B.; Albernaz, L.C.; Espindola, L.S. Residual Larvicidal Activity of Quinones against Aedes aegypti. Molecules 2020, 25, 3978. [Google Scholar] [CrossRef]
  64. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef] [Green Version]
  65. De Oliveira, G.; Carnevale Neto, F.; Demarque, D.; de Sousa Pereira-Junior, J.; Sampaio Peixoto Filho, R.; de Melo, S.; da Silva Almeida, J.; Lopes, J.; Lopes, N. Dereplication of Flavonoid Glycoconjugates from Adenocalymma imperatoris-maximilianii by Untargeted Tandem Mass Spectrometry-Based Molecular Networking. Planta Med. 2016, 83, 636–646. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 2498–2504. [Google Scholar] [CrossRef] [PubMed]
Molecules 27 01588 g001 550
Figure 1. Strategy for the discovery of potential bioactive classes: spectral similarity networking (GC-MS data) combined with biological assays (larvicidal assay—LC50 values).
Figure 1. Strategy for the discovery of potential bioactive classes: spectral similarity networking (GC-MS data) combined with biological assays (larvicidal assay—LC50 values).
Molecules 27 01588 g001
Molecules 27 01588 g002 550
Figure 2. Molecular network filtered by retention time (RT). The color gradient is represented by yellow (initial) and red (end), while the node size represents the relative abundance of ions.
Figure 2. Molecular network filtered by retention time (RT). The color gradient is represented by yellow (initial) and red (end), while the node size represents the relative abundance of ions.
Molecules 27 01588 g002
Molecules 27 01588 g003 550
Figure 3. Molecular networks filtered for the relative abundance of ions present in the studied families. The color gradient represents ion (compound) abundance in the essential oils (family). Yellow—low or no abundance; blue—high abundance. The node size also represents the total relative abundance of ions.
Figure 3. Molecular networks filtered for the relative abundance of ions present in the studied families. The color gradient represents ion (compound) abundance in the essential oils (family). Yellow—low or no abundance; blue—high abundance. The node size also represents the total relative abundance of ions.
Molecules 27 01588 g003
Molecules 27 01588 g004 550
Figure 4. Molecular networks filtered by the calculated LC50 values (24 h larvae mortality) of the essential oils for each node. (a) Average of LC50 values calculated qualitatively (not considering the relative abundance of ions). (b) Relative average of LC50 values considering the relative abundance of ions.
Figure 4. Molecular networks filtered by the calculated LC50 values (24 h larvae mortality) of the essential oils for each node. (a) Average of LC50 values calculated qualitatively (not considering the relative abundance of ions). (b) Relative average of LC50 values considering the relative abundance of ions.
Molecules 27 01588 g004
Molecules 27 01588 g005 550
Figure 5. Molecular network filtered for compound annotation (nodes) using the GNPS library and an in-house NIST database. The annotated compounds were classified using the NP classifier ontology. The colors of the ellipse represent the annotated monoterpenes (orange) and sesquiterpenes (purple). At the bottom, the groupings of mono- and sesquiterpenes with their respective subclasses are expanded.
Figure 5. Molecular network filtered for compound annotation (nodes) using the GNPS library and an in-house NIST database. The annotated compounds were classified using the NP classifier ontology. The colors of the ellipse represent the annotated monoterpenes (orange) and sesquiterpenes (purple). At the bottom, the groupings of mono- and sesquiterpenes with their respective subclasses are expanded.
Molecules 27 01588 g005
Molecules 27 01588 g006 550
Figure 6. Molecular network filtered by LC50 values calculated for larval mortality at 48 h of Ae. aegypti for monoterpenes: α-fenchene (>100 µg/mL), eucalyptol (>100 µg/mL), menthol (>100 µg/mL), citronellol (65.3 µg/mL), citronellal (57.8 µg/mL), cymol (41.7 µg/mL), citral (40.1 µg/mL), α-phelandrene (40.1 µg/mL), D-limonene (27.1 µg/mL). Red nodes represent high larvicidal activity and dark blue nodules represent LC50 values > 100 µg/mL.
Figure 6. Molecular network filtered by LC50 values calculated for larval mortality at 48 h of Ae. aegypti for monoterpenes: α-fenchene (>100 µg/mL), eucalyptol (>100 µg/mL), menthol (>100 µg/mL), citronellol (65.3 µg/mL), citronellal (57.8 µg/mL), cymol (41.7 µg/mL), citral (40.1 µg/mL), α-phelandrene (40.1 µg/mL), D-limonene (27.1 µg/mL). Red nodes represent high larvicidal activity and dark blue nodules represent LC50 values > 100 µg/mL.
Molecules 27 01588 g006
Table
Table 1. Commercial essential oil larvicidal assay (mortality rate at 24 h and 48 h) results and corresponding LC50 values determined against Ae. aegypti.
Table 1. Commercial essential oil larvicidal assay (mortality rate at 24 h and 48 h) results and corresponding LC50 values determined against Ae. aegypti.
SampleSpecies (Family)BatchMajor Compound (%)Mortality
250 µg/mL
(%, 24 h)		Mortality
250 µg/mL
(%, 48 h)		LC50
(µg/mL)
(24 h)
01Juniperus communis (Cupressaceae)180113α-pinene (38.9)7582.5135.2
02Origanum majorana (Lamiacae)180319terpinen-4-ol (25.2)82.580121.3
03Cymbopogon martini (Poaceae)180227geraniol (80.6)87.592.573.88
07Boswellia carteri (Burseraceae)180217α-pinene (43.8)42.575129.8
08Mentha piperita (Lamiaceae)180418menthol (45.7)10010095.29
09Citrus aurantium var. amara (Rutaceae)180206D-limonene (96.9)42.560177.1
10Eucalyptus citriodora (Myrtaceae)180307citronelal (74.4)10010023.26
11Eucalyptus globulus (Myrtaceae)180205eucalyptol (89.9)87.597.5276.6
14Lavandula angustifolia (Lamiaceae)180408linalyl acetate (63.0)10010085.88
16Lavandula hybrida (Lamiaceae)180403linalool (36.2)7070109
18Cymbopogon flexuosus (Poaceae)180326citral (50.6)10010041.66
19Cymbopogon nardus (Poaceae)180306citronelal (45.9)10010031.25
20Cedrus atlantica (Pinaceae)180226β-himachalene (54.7)6065269.1
21Rosmarinus officinalis (Lamiaceae)180415camphor (23.6)909080.33
23Citrus aurantium subsp. Bergamia (Rutaceae)180402D-limonene (38.2)10010099.57
24Pelargonium graveolens (Geraniaceae)171234citronellol (35.3)10010078.32
27Litsea cubeba (Lauraceae)180412citral (47.7)10010032.74
31Salvia sclareia (Lamiaceae)180405linalyl acetate (71.0)6075120
33Amyris balsamifera (Rutaceae)180214valencene (21.5)10010099.51
34Eucalyptus staigeriana (Myrtaceae)180207D-limonene (29.2)10010043.13
N.C. 1<1% DMSO- ---
P. C. 2Temephos (100% mortality)--0.350.350.019
1—negative control; 2—positive control.
Table
Table 2. List of annotated compounds including the retention time (min), precursor ion values (m/z), samples and relative LC50 values.
Table 2. List of annotated compounds including the retention time (min), precursor ion values (m/z), samples and relative LC50 values.
RT (min)Compoundm/z *SamplesRelative LC50 **
(µg/mL)
5.01thujene93.11, 2, 9, 10, 11, 16, 18, 19, 23, 24, 31125.6
5.21pinene91.11, 2, 7, 8, 9, 10, 11, 14, 16, 18, 19, 21, 23, 24, 27, 31105.9
5.21fenchene93.11, 2, 7, 8, 9, 10, 11, 14, 16, 18, 19, 20, 21, 23, 24, 27, 31, 33123.2
5.58camphene93.11, 2, 9, 10, 14, 16, 18, 19, 23, 27, 3184.1
6.20phellandrene93.11, 2, 7, 9, 10, 11, 18, 20, 23, 24, 27, 31128.5
6.31pinene93.11, 2, 8, 9, 10, 11, 14, 18, 23, 24, 27, 31, 33116.0
6.52sulcatone43.01, 2, 3, 7, 8, 9, 10, 11, 14, 16, 18, 19, 20, 24, 27, 31, 3355.1
6.64myrcene77.01, 2, 3, 9, 10, 11, 14, 18, 19, 23, 24, 31, 33130.2
7.06ethylene diglycol monoethyl ether93.11, 2, 9, 10, 11, 14, 18, 19, 23, 24, 27, 31127.5
7.25terpinene93.11, 9, 10, 11, 16, 18, 23126.5
7.44terpinene136.11, 2, 9, 10, 23, 24, 27120.3
7.68cymol119.11, 2, 3, 9, 10, 11, 14, 16, 18, 19, 20, 23, 24, 27, 31, 33124.7
7.83D-limonene68.11, 2, 3, 8, 9, 10, 11, 14, 16, 18, 19, 20, 23, 24, 27, 31, 33119.6
7.91eucalyptol43.01, 2, 3, 7, 8, 9, 10, 11, 14, 16, 18, 19, 20, 23, 24, 27, 31229.6
8.44cymene93.11, 2, 3, 9, 10, 11, 14, 16, 18, 19, 24, 33150.1
8.83phellandrene93.11, 2, 7, 9, 10, 11, 14, 18, 20, 23, 24, 27, 31120.3
9.13sabinene hydrate71.12, 10, 18120.9
9.90terpinolene93.11, 2, 9, 10, 11, 14, 18, 20, 23, 24, 27124.0
10.28linalool71.11, 2, 3, 7, 9, 10, 11, 16, 18, 19, 20, 23, 24, 27, 31, 33105.9
12.05iso-pulegol41.09, 10, 18, 19, 20, 23, 27, 3186.5
12.06camphor95.19, 10, 16, 18, 20, 23, 2786.8
12.40citronellal41.12, 10, 19, 20, 27, 3151.9
12.86menthol112.110, 18, 2793.0
12.89endo-Borneol95.11, 2, 9, 10, 16, 18, 19, 21, 23, 27, 3394.8
12.90cis-p-menthan-3-one69.110, 16, 18, 2396.7
13.37terpinen-4-ol71.11, 2, 7, 9, 10, 11, 16, 18, 31121.5
13.90terpineol93.11, 2, 9, 10, 11, 14, 16, 18, 19, 20, 21, 23, 24, 27, 31, 33125.2
15.45citronellol69.11, 2, 3, 7, 11, 18, 19, 20, 24, 27, 31, 3348.3
15.98neral41.13, 10, 11, 18, 19, 20, 24, 27, 3139.6
16.59geraniol69.12, 3, 7, 10, 11, 16, 18, 19, 20, 24, 27, 31, 3397.2
16.59linalyl acetate93.12, 3, 7, 10, 11, 16, 18, 19, 20, 23, 24, 27, 31, 33112.0
17.25citral69.13, 7, 10, 11, 16, 19, 20, 24, 27, 31, 3337.6
17.39citronellyl formate109.110, 16, 24, 2784.5
17.88unknown95.11, 2, 9, 16, 18, 2392.9
18.09lavandulol acetate69.116, 18104.5
18.56unknown69.13, 19, 20, 27, 3378.2
20.52unknown119.11, 7, 9, 21144.5
20.67citronellol acetate81.11, 20, 27, 31, 3440.6
21.15unknown69.12, 3, 7, 11, 16, 18, 19, 24, 27, 33114.3
21.59unknown41.01, 7, 9, 19, 24, 31, 3376.4
21.60unknown119.11, 3, 7, 9, 10, 19, 27, 31, 3392.6
21.95neryl acetate69.11, 2, 3, 7, 11, 16, 18, 19, 20, 24, 27, 31, 3392.3
22.28elemene81.11, 7, 8, 9, 10, 2058.7
23.38caryophyllene79.11, 2, 3, 7, 8, 9, 10, 11, 16, 18, 19, 23, 27, 31, 33, 3497.8
24.60himachalene93.17, 8, 21, 34247.8
24.75humulene93.11, 2, 3, 7, 8, 9, 10, 11, 18, 19, 20, 23, 27, 33, 3479.1
25.00acoradiene93.11, 8, 9, 3466.1
25.69longifolene93.11, 7, 8, 9, 20, 21, 27, 34221.5
25.86germacrene91.11, 7, 8, 9, 10, 18, 19, 20, 21, 27, 33, 3493.2
26.44unknown91.11, 2, 7, 8, 9, 10, 11, 21, 27, 34100.9
26.50curcumene121.11, 2, 7, 9, 10, 11, 21, 33, 3498.2
26.63himachalene119.11, 7, 8, 9, 16, 20, 21, 34257.1
26.96unknown69.17, 8, 9, 18, 21, 24, 3455.1
27.18unknown161.11, 7, 8, 9, 18, 19, 2069.0
27.31unknown122.17, 8, 3465.9
27.54cadiene119.11, 7, 8, 9, 10, 18, 19, 20, 21, 27, 34128.1
28.54elemol107.19, 20, 3491.4
29.81unknown91.11, 2, 3, 8, 9, 16, 18, 19, 21, 31, 33100.1
30.46unknown95.17, 27, 3438.6
31.95unknown91.11, 2, 7, 8, 9, 18, 20, 21, 34103.8
32.02unknown161.11, 7, 9, 18, 20, 3489.1
32.48unknown95.11, 7, 8, 9, 20, 3483.9
34.92unknown69.13, 7, 3460.9
*—precursor ion; **—relative average LC50 of each node.
Table
Table 3. Mzmine 2 parameters for the commercial essential oil MS data analysis.
Table 3. Mzmine 2 parameters for the commercial essential oil MS data analysis.
FeatureLVL 1LVL 2Value
Mass DetectionScans 3.5–50.0 min
Mass Detector Centroid
Noise Level1.0 × 103
ADAP Chrom.
Build		Min. group size in # of scans 15
Group intensity threshold 1.0 × 103
Min. highest intensity 1.0 × 103
m/z tolerance 0.01 m/z
Chrom. deconv.Wavelets (ADAP)S/N threshold7
S/N estimatorIntensity window SN
Min feature height1
Coef./area threshold30
Peak duration 1.00
RT wavelet range0.15
m/z center calculationMedian
Spec. Deconv.Multivariate Curve ResolutionDeconvolution window width (min)0.15
Retention time tolerance (min)0.02
Minimum number of peaks1
ADAP AlignerMin confidence (0 to 1) 0.05
Retention time tolerance 0.1 (min)
m/z tolerance 0.1 (m/z)
Score threshold (0 to 1) 0.75
Score weight (0 to 1) 0.1
Retention time similarityCross-correlation
Gap fillingPeak finder multithreaded
Intensity tolerance0.1%
m/z tolerance0.2 m/z
retention time tolerance 0.1 min
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pilon, A.C.; Del Grande, M.; Silvério, M.R.S.; Silva, R.R.; Albernaz, L.C.; Vieira, P.C.; Lopes, J.L.C.; Espindola, L.S.; Lopes, N.P. Combination of GC-MS Molecular Networking and Larvicidal Effect against Aedes aegypti for the Discovery of Bioactive Substances in Commercial Essential Oils. Molecules 2022, 27, 1588. https://doi.org/10.3390/molecules27051588

AMA Style

Pilon AC, Del Grande M, Silvério MRS, Silva RR, Albernaz LC, Vieira PC, Lopes JLC, Espindola LS, Lopes NP. Combination of GC-MS Molecular Networking and Larvicidal Effect against Aedes aegypti for the Discovery of Bioactive Substances in Commercial Essential Oils. Molecules. 2022; 27(5):1588. https://doi.org/10.3390/molecules27051588

Chicago/Turabian Style

Pilon, Alan Cesar, Marcelo Del Grande, Maíra R. S. Silvério, Ricardo R. Silva, Lorena C. Albernaz, Paulo Cézar Vieira, João Luis Callegari Lopes, Laila S. Espindola, and Norberto Peporine Lopes. 2022. "Combination of GC-MS Molecular Networking and Larvicidal Effect against Aedes aegypti for the Discovery of Bioactive Substances in Commercial Essential Oils" Molecules 27, no. 5: 1588. https://doi.org/10.3390/molecules27051588

Article Metrics

Back to TopTop